Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
26
|
pubmed:dateCreated |
1972-8-25
|
pubmed:language |
hun
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
0030-6002
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
25
|
pubmed:volume |
113
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1530-3
|
pubmed:dateRevised |
2009-10-21
|
pubmed:meshHeading | |
pubmed:year |
1972
|
pubmed:articleTitle |
[Clinical trials with the beta adrenergic blocking agent Visken].
|
pubmed:publicationType |
Journal Article
|